Journal Article

A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome

Ren, Zhenxing, Lin, Chengyuan, Zhang, Xuan, Zhao, Ling, Chen, Yang, Lu, Lin, Cai, Zongwei, Huang, Tao, Ning, Ziwan, Han, Lijuan, Shang, Xiaoxiao, Yang, Wei, Yang, Zhen, Huang, Fengjie, Xiao, Haitao, Zhai, Lixiang, Lu, Aiping, Jia, Wei, Sun, Silong, El-Nezami, Hani, Qiu, Qinwei, Huang, Runyue, Zhong, Linda L.D., Fang, Xiaodong, Cheng, Chungwah, Bian, Zhaoxiang, Lam, Waiching, Chen, Dongfeng

2020

Overview

An excess of fecal bile acids (BAs) is thought to be one of the mechanisms for diarrhea-predominant irritable bowel syndrome (IBS-D). However, the factors causing excessive BA excretion remain incompletely studied. Given the importance of gut microbiota in BA metabolism, we hypothesized that gut dysbiosis might contribute to excessive BA excretion in IBS-D. By performing BA-related metabolic and metagenomic analyses in 290 IBS-D patients and 89 healthy volunteers, we found that 24.5% of IBS-D patients exhibited excessive excretion of total BAs and alteration of BA-transforming bacteria in feces. Notably, the increase in Clostridia bacteria (e.g., C. scindens) was positively associated with the levels of fecal BAs and serum 7α-hydroxy-4-cholesten-3-one (C4), but negatively correlated with serum fibroblast growth factor 19 (FGF19) concentration. Furthermore, colonization with Clostridia-rich IBS-D fecal microbiota or C. scindens individually enhanced serum C4 and hepatic conjugated BAs but reduced ileal FGF19 expression in mice. Inhibition of Clostridium species with vancomycin yielded opposite results. Clostridia-derived BAs suppressed the intestinal FGF19 expression in vitro and in vivo. In conclusion, this study demonstrates that the Clostridia-rich microbiota contributes to excessive BA excretion in IBS-D patients, which provides a mechanistic hypothesis with testable clinical implications.

• Publisher: American Society for Clinical Investigation
• Subject: Amino acids / Analysis / Antibacterial agents / Antibiotics / Bacteria / Bile / Bile acids / Biomedical research / Clostridia / Colonization / Deoxycholic acid / Diarrhea / Digestive system / Dysbacteriosis / Excretion / Fecal microflora / Feces / Fibroblast growth factors / Fibroblasts / Gastrointestinal tract / Growth factors / Intestinal microflora / Intestine / Irritable bowel syndrome / Metabolism / Metagenomics / Microbiota / Microbiota (Symbiotic organisms) / Physiological aspects / Vancomycin